当前位置:首页 - 行情中心 - 阳普医疗(300030) - 财务分析 - 现金流量表

阳普医疗

(300030)

  

流通市值:18.46亿  总市值:20.96亿
流通股本:2.72亿   总股本:3.09亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金405,989,384.64266,465,688.85127,742,756.84569,419,588.1
  收到的税费返还3,638,184.291,505,212.41504,676.428,729,838.01
  收到其他与经营活动有关的现金9,035,898.527,801,048.477,129,978.997,356,618.37
  经营活动现金流入小计418,663,467.45275,771,949.73135,377,412.25585,506,044.48
  购买商品、接受劳务支付的现金158,178,855.36106,527,345.7752,122,279.84223,393,708.27
  支付给职工以及为职工支付的现金108,041,967.4971,584,861.235,484,309.23157,832,631.41
  支付的各项税费18,141,333.7512,410,767.345,642,761.5532,492,455.95
  支付其他与经营活动有关的现金60,612,441.5128,490,317.813,455,749.7761,891,505.38
  经营活动现金流出小计344,974,598.11219,013,292.11106,705,100.39475,610,301.01
  经营活动产生的现金流量净额73,688,869.3456,758,657.6228,672,311.86109,895,743.47
二、投资活动产生的现金流量:
  收回投资收到的现金899,2350011,000,000
  取得投资收益收到的现金12,546,806.112,248,850.7512,014,894.0926,523,428.84
  处置固定资产、无形资产和其他长期资产收回的现金净额199,112.75199,112.7588,803.21,578,973.24
  处置子公司及其他营业单位收到的现金净额-00-
  收到的其他与投资活动有关的现金193,500,000137,500,00043,500,000262,350,000
  投资活动现金流入小计207,145,153.85149,947,963.555,603,697.29301,452,402.08
  购建固定资产、无形资产和其他长期资产支付的现金23,303,448.0317,275,157.9911,901,226.9424,124,354.1
  投资支付的现金-0010,000,000
  取得子公司及其他营业单位支付的现金-00-
  支付其他与投资活动有关的现金215,500,000157,500,00086,500,000262,350,000
  投资活动现金流出小计238,803,448.03174,775,157.9998,401,226.94296,474,354.1
  投资活动产生的现金流量净额-31,658,294.18-24,827,194.49-42,797,529.654,978,047.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金-000
  其中:子公司吸收少数股东投资收到的现金-00-
  取得借款收到的现金36,592,998.5326,592,998.5325,859,675231,400,000
  收到其他与筹资活动有关的现金-000
  筹资活动现金流入小计36,592,998.5326,592,998.5325,859,675231,400,000
  偿还债务支付的现金129,671,527.6180,114,351.7445,557,175.87423,074,703.48
  分配股利、利润或偿付利息支付的现金6,977,571.536,551,856.92800,218.658,548,954.27
  其中:子公司支付给少数股东的股利、利润5,091,210.755,091,210.7503,052,500
  支付其他与筹资活动有关的现金1,693,897.391,642,692.08210,707.993,096,529.17
  筹资活动现金流出小计138,342,996.5388,308,900.7446,568,102.51434,720,186.92
  筹资活动产生的现金流量净额-101,749,998-61,715,902.21-20,708,427.51-203,320,186.92
四、汇率变动对现金及现金等价物的影响-1,015,335.59-715,189.47-374,189.77317,527.15
五、现金及现金等价物净增加额-60,734,758.43-30,499,628.55-35,207,835.07-88,128,868.32
  加:期初现金及现金等价物余额159,202,212.68159,202,212.68159,202,212.68247,331,081
  期末现金及现金等价物余额98,467,454.25128,702,584.13123,994,377.61159,202,212.68
补充资料:
  净利润-31,320,389.47-15,214,212.98
  资产减值准备--7,940,782.23-28,920,118.42
  固定资产和投资性房地产折旧-12,890,668.35-27,002,555.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,890,668.35-27,002,555.92
  无形资产摊销-1,984,136.49-3,877,241.17
  长期待摊费用摊销-915,469.6-1,980,201.48
  处置固定资产、无形资产和其他长期资产的损失--18,517.63--2,087,236.69
  固定资产报废损失--20,970.37--664,247.26
  公允价值变动损失-6,071,000-10,171,400
  财务费用-1,571,751.82-5,632,237.79
  投资损失--1,032,405.86--20,484,949.48
  递延所得税-2,400,246.11-3,535,653.43
  其中:递延所得税资产减少-3,917,996.11-3,169,935.44
    递延所得税负债增加--1,517,750-365,717.99
  存货的减少--12,784,399.17-9,119,063.36
  经营性应收项目的减少-28,358,950.78-141,924,850.51
  经营性应付项目的增加--2,318,271.84--117,324,297.66
  其他--4,897,189.12--
  现金的期末余额-128,702,584.13-159,202,212.68
  减:现金的期初余额-159,202,212.68-247,331,081
  现金及现金等价物的净增加额--30,499,628.55--88,128,868.32
公告日期2026-10-282026-08-152026-04-222026-04-09
审计意见(境内)标准无保留意见
TOP↑